Correction\nto “Evaluation of High-Affinity\nMonoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved\nFRET”

Publication Details

Journal
Figshare
Published
2024-11-29
DOI
https://doi.org/10.1021/acsmedchemlett.4c00555.s001
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction\nto “Evaluation of High-Affinity\nMonoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved\nFRET”

Figshare
HER2/EGFR in Cancer Research
article

Correction\nto “Evaluation of High-Affinity\nMonoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved\nFRET”

article en

Abstract

No abstract available for this paper.
Figshare
Openalex Percentile: Top 54%
HER2/EGFR in Cancer Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction\nto “Evaluation of High-Affinity\nMonoclonal Antibodies and Antibody-Drug Conjugates by Homogenous Time-Resolved\nFRET” · Figshare (2024) | TGRS Research Map | TGRS